Saltar al contenido
Merck
Todas las fotos(2)

Key Documents

View All Documentation

GF62158596

Lithium

foil, not light tested, 38x200mm, thickness 0.20mm, as rolled, 99.9%

Sinónimos:

Lithium, LI000220

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(2)

About This Item

Fórmula lineal:
Li
Número de CAS:
7439-93-2
Peso molecular:
6.94
MDL number:
MFCD00134051
UNSPSC Code:
12141803
PubChem Substance ID:
329809388
NACRES:
NA.23

assay

99.9%

form

foil

manufacturer/tradename

Goodfellow 621-585-96

resistivity

9.446 μΩ-cm, 20°C

size × thickness

38x200 mm × 0.20 mm

bp

1342 °C (lit.)

mp

180 °C (lit.)

density

0.534 g/mL at 25 °C (lit.)

SMILES string

[Li]

InChI

1S/Li

InChI key

WHXSMMKQMYFTQS-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Storage Class

4.3 - Hazardous materials which set free flammable gases upon contact with water

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

Lo sentimos, en este momento no disponemos de COAs para este producto en línea.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Yingying Lu et al.
Nature materials, 13(10), 961-969 (2014-08-12)
Rechargeable lithium, sodium and aluminium metal-based batteries are among the most versatile platforms for high-energy, cost-effective electrochemical energy storage. Non-uniform metal deposition and dendrite formation on the negative electrode during repeated cycles of charge and discharge are major hurdles to
Mustafa Khasraw et al.
BMC medicine, 10, 131-131 (2012-11-06)
Neurocognitive impairment is being increasingly recognized as an important issue in patients with cancer who develop cognitive difficulties either as part of direct or indirect involvement of the nervous system or as a consequence of either chemotherapy-related or radiotherapy-related complications.
Annemiek Dols et al.
International clinical psychopharmacology, 28(6), 287-296 (2013-07-23)
Side effects are among the most frequent reasons preventing patients from taking their medication. Although the management of side effects is an important issue in clinical practice, particularly in patients with physical comorbidities, research on clinical management of side effects
Rasmus W Licht
CNS neuroscience & therapeutics, 18(3), 219-226 (2011-11-11)
Still after more than 50 years, lithium is a major treatment of bipolar disorder, even though it has not been promoted by the pharmaceutical industry over the last decades. In recent years the evidence base on lithium for bipolar disorder
Jian Liu et al.
Chemical communications (Cambridge, England), 47(47), 12578-12591 (2011-08-25)
Yolk/shell or 'rattle-typed' nanomaterials with nanoparticle cores inside hollow shells are interesting among the complex hollow nanostructures. Yolk/shell nanoparticles (YSNs) are promising functional nanomaterials for a variety of applications such as catalysis, delivery, lithium-ion batteries and biosensors due to their
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico